These names were among the stocks chosen for MoneyShow's Top Picks 2020 Report.
As it smooths out the wrinkles from 2019, this pharmaceutical manufacturer should have a healthy year.
In times of overheated valuations, cautious investors should turn to the best-in-breed dividend payers.
These names are poised to benefit from both longer-term sector trends as well as near-term geopolitical tensions.
General Mills has a long history of generating consistent growth over many decades -- and a high yield of 3.7%.
CLGX has ample room to boost its quarterly dividend payment down the road, especially if it throttles back its buy back activity.
The energy space is showing some attractive value opportunities.
These healthcare stalwarts look attractive for growth and income.
Bristol-Myers Squibb, Amgen and Abbott Labs all recently raised their dividends and should prosper amid the aging population.
Don't let Boeing's problems lead you to ignore attractive opportunities in the sector.